CMS finalized the 2026 Medicare Physician Fee Schedule with minor reforms and introduced an interactive dashboard tracking payment rates across Medicare payment systems starting January 2026.
Medicare telehealth waivers and hospital-at-home programs expired on Sept. 30, risking reduced access to telehealth services for Medicare patients and operational pauses in hospital-at-home programs. Stakeholders call for permanent regulatory solutions.
Senate GOP leaders consider offering a future vote on ACA subsidy extensions to break the government shutdown deadlock amid health insurance market concerns.
ACA federal tax credits supporting over 20 million Americans face expiration amid 2025 government shutdown, causing health insurance premium spikes, notably in New York counties. Understand the regulatory and market impacts for insurers and insureds.
An analysis of New York's minimal reliance on ACA tax credits due to the Essential Plan, the impact of enhanced subsidies, and upcoming federal policy changes affecting state health coverage financing.
In 2025, U.S. negotiations over Medicaid funding cuts and ACA tax subsidy extensions could reshape health insurance access and costs, affecting millions and insurance markets nationwide.
New federal legislation introduces significant cuts to Medicaid and ACA marketplace subsidies, tightens eligibility requirements, and may reduce coverage for millions by 2034.
The potential expiration of enhanced ACA subsidies at the end of 2024 could lead to significant premium increases and coverage losses, intensifying debates on federal healthcare spending and insurance affordability.
UnitedHealth will stop offering Medicare Advantage plans in 16 U.S. counties by 2026 due to CMS funding cuts and rising healthcare costs, impacting 180,000 members and shifting focus to sustainable care models.
The impending U.S. federal government shutdown threatens major disruptions in healthcare funding, federal employee furloughs, and regulatory delays impacting insurers and providers. Key agencies like HHS and FDA face operational challenges amid budget impasses.
